Company / Inventory
Xeris Biopharma Holdings, Inc. Inventory History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$68.7M
FY2025
5-year range
$18.1M / $68.7M
FY2021-FY2025
Trend
+42.5%
vs FY2024
Sector context
#52 of 105
Health Care
What the data says
At $69M, Xeris Biopharma Holdings, Inc.'s inventory ranks #52 of 105 in the Health Care sector. Inventory has increased for 5 consecutive years, from $8M in FY2020 to $69M in FY2025.
Based on SEC 10-K filings.
$69M in FY2025 with a 5-year CAGR of +52.4%.
Improved from $39M to $69M over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +40.5%
- 5-Year CAGR
- +52.4%
- 10-Year CAGR
- -
Sector benchmark
#52 of 105 in Health CareTop 50% of 105This company $68.7M Sector average $885.3M
▼
-92.2% below sector average
Key checks
Key Insights
- Xeris Biopharma Holdings, Inc.'s inventory has grown for 5 consecutive years.
- 5-year CAGR of +52.4%, indicating consistent growth.
- In FY2025, inventory increased 42.5% year-over-year.
- Ranks #52 out of 105 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.26 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $68.7M | +42.5% |
| FY2024 | $48.2M | +24.0% |
| FY2023 | $38.8M | +57.0% |
| FY2022 | $24.7M | +36.5% |
| FY2021 | $18.1M | +116.9% |
| FY2020 | $8.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026